Ignite Creation Date:
2025-12-24 @ 11:15 PM
Ignite Modification Date:
2026-04-11 @ 8:55 AM
Study NCT ID:
NCT01232556
Status:
TERMINATED
Last Update Posted:
2019-01-08
First Post:
2010-10-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy
Sponsor:
Pfizer
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lymphoma, Non-Hodgkin | View |